Access to anti-retroviral drugs, female in Botswana
Botswana: Access to anti-retroviral drugs, female was 98.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Botswana, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
In 2024, access to anti-retroviral drugs, female in Botswana stood at 98.0%. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 40.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Botswana peaked at 98.0% in 2023 and was at its lowest, 0.0%, in 2000.
That places Botswana 1st out of 141 countries with data for 2024, putting it in the top 10%.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Botswana, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 1.0% | — |
| 2002 | 2.0% | +100.0% |
| 2003 | 5.0% | +150.0% |
| 2004 | 12.0% | +140.0% |
| 2005 | 18.0% | +50.0% |
| 2006 | 24.0% | +33.3% |
| 2007 | 28.0% | +16.7% |
| 2008 | 35.0% | +25.0% |
| 2009 | 46.0% | +31.4% |
| 2010 | 51.0% | +10.9% |
| 2011 | 55.0% | +7.8% |
| 2012 | 65.0% | +18.2% |
| 2013 | 67.0% | +3.1% |
| 2014 | 70.0% | +4.5% |
| 2015 | 76.0% | +8.6% |
| 2016 | 81.0% | +6.6% |
| 2017 | 84.0% | +3.7% |
| 2018 | 90.0% | +7.1% |
| 2019 | 91.0% | +1.1% |
| 2020 | 93.0% | +2.2% |
| 2021 | 96.0% | +3.2% |
| 2022 | 97.0% | +1.0% |
| 2023 | 98.0% | +1.0% |
| 2024 | 98.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 17.1% | 0.0% | 46.0% | 10 |
| 2010s | 73.0% | 51.0% | 91.0% | 10 |
| 2020s | 96.4% | 93.0% | 98.0% | 5 |
Countries ranked near Botswana
More gender data for Botswana
- Child population (UN estimates and projections) 855.49 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.6449 % change on previous year (2030)
- Population 1,910 (2030)
- Working-age population (UN estimates and projections) 1,910 (2030)
- Age population, age 00, female, interpolated 29,466 (2025)
- Age population, age 00, male, interpolated 30,240 (2025)
- Age population, age 01, female, interpolated 29,267 (2025)
- Age population, age 01, male, interpolated 30,023 (2025)
- Age population, age 02, female, interpolated 29,174 (2025)
- Age population, age 02, male, interpolated 29,925 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Botswana?
- Access to anti-retroviral drugs, female in Botswana was 98.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Botswana?
- The highest recorded value was 98.0% in 2023.
- What is the lowest access to anti-retroviral drugs, female recorded in Botswana?
- The lowest recorded value was 0.0% in 2000.
- How does Botswana rank for access to anti-retroviral drugs, female?
- Botswana ranks 1st out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Botswana?
- Over the last ten years it is up 40.0%. The long-run trend across the full record is volatile.
- Where does this Botswana data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.